Clinical Trial Update: An Open Label Pharmacokinetic, Safety And Efficacy Study Of Maraviroc In Combination With Background Therapy For The Treatment Of HIV-1 Infected, CCR5 -Tropic Children [Phase 2]

View source ↗

Summary

Open-label Phase 2 trial evaluating maraviroc with background therapy in HIV-1–infected CCR5-tropic children; aims to assess pharmacokinetics, safety, and effic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Maraviroc (maraviroc)

Snippet

Sponsor: ViiV Healthcare | Conditions: Human Immunodeficiency Virus | Phase 2 | Status: UNKNOWN | Results posted: 2016-02-25